ABVD
Doxorubicin  25 mg/m2 iv d1 and 15
Bleomycin 10 U/m2 iv d1 and 15
Vinblastine 6 mg/m2 iv d1 and 15
Dacarbazine (DTIC) 375 mg/m2 iv d1 and 15
Q4w

BEACOPP 
Bleomycin 10 IU/m2 iv d8
Etoposide (VP-16) 100 mg/m2/d iv d1-3
Doxorubicin  25 mg/m2 iv d1
Cyclophosphamide  650 mg/m2 iv d1
Vincristine 1.4 mg/m2 (max 2 mg) iv d8
Procarbazine 100 mg/m2 po qd d1-7
Prednisone 40 mg/m2 po qd d1-7
Q3w

Increased-dose BEACOPP
Bleomycin 10 IU/m2 iv d8
Etoposide (VP-16) 200 mg/m2/d iv d1-3
Doxorubicin  35 mg/m2 iv d1
Cyclophosphamide  1250 mg/m2 iv d1
Vincristine 1.4 mg/m2 (max 2 mg) iv d8
Procarbazine 100 mg/m2 po qd d1-7
Prednisone 40 mg/m2 po qd d1-14
Filgrastim support
Q3w

Stanford V
Nitrogen mustard 6 mg/m2 iv d1
Doxorubicin  25 mg/m2 iv d1 and 15
Vinblastine 6 mg/m2 iv d1 and 15
Vincristine 1.4 mg/m2 iv d8 and 22
Bleomycin 5 U/m2 iv d8 and 22
Etoposide (VP-16) 60 mg/m2 iv d15 and 16
Prednisone 40 mg po qod x 10 weeks, then taper by 10 mg every other day between weeks 10 and 12
Q4w x 3 cycles (12 weeks)
For patients older than 50, reduce Vinblastine to 4 mg/m2 amd Vincristine to 1 mg/m2 in cycle 3.
Bactrim DS po bid
Acyclovir 200 mg po tid
Ketoconazole 200 mg po qd
2-4 weeks after chemotherapy, consolidation radiotherapy to 36 Gy for lymph nodes > or equal to 5 cm and/or macroscopic nodules in spleen

MOPP
Nitrogen mustard 6 mg/m2 iv d1 and 8
Vincristine 1.4 mg/m2 iv d1 and 8
Procarbazine 100 mg/m2 po qd d1-14
Prednisone 40 mg/m2 po qd d1-14
Q4w x 6 cycles
 
GVD
For transplant-naive patients:
Gemcitabine 1000 mg/m2 iv d1, 8
Vinorelbine  20 mg/m2 iv d1, 8
Pegylated liposomal doxorubicin  15 mg/m2 iv d1, 8
Q3w
For post-transplant patients:
Gemcitabine 800 mg/m2 iv d1, 8
Vinorelbine  15 mg/m2 iv d1, 8
Pegylated liposomal doxorubicin  10 mg/m2 iv d1, 8
Q3w